Research Article
Impact of Nuclear Interleukin-1 Alpha and EGFR Expression on Recurrence and Survival Outcomes in Oral Squamous Cell Carcinomas
Table 1
Patient characteristics by IL-1α Immunostaining.
| | | Nuclear IL-1α | | Cytoplasmic IL-1α | | Characteristics | Total (n) | 2 (%) | 1 (%) | 0 (%) | p-value | 2 (%) | 1 (%) | 0 (%) | p-value |
| Number of Evaluable | 141 | | | | | | | | | Subjects | Sex | | | | | | | | | | Male | 82 | 57 | 58 | 57 | 0.99 | 50 | 58 | 59 | 0.37 | Female | 59 | 43 | 42 | 43 | 50 | 42 | 41 | Avg Age at Diagnosis | | | | | | | | | Male | 58 | 59 | 58 | 54 | 0.74 | 53 | 57 | 62 | 0.28 | (avg (range)) | (31-81) | (37-76) | (31-81) | (44-69) | | (31-81) | (37-73) | Female | 66 | 58 | 68 | 63 | 78 | 67 | 61 | (avg (range)) | (19-33) | (19-81) | (20-93) | (58-73) | | (19-93) | (44-80) | Smoking History | | | | | | | | | | Active Smoker | 56 | 36 | 42 | 29 | <0.0001 | 0 | 39 | 44 | <0.0001 | Never Smoker | 49 | 29 | 38 | 14 | 100 | 34 | 33 | Quit <10 Years | 13 | 14 | 7 | 29 | 0 | 9 | 11 | Quit >10 Years | 17 | 11 | 11 | 29 | 0 | 13 | 11 | Tobacco Chewer | 6 | 11 | 3 | 0 | 0 | 5 | 0 | Tumor Site | | | | | | | | | | Alveolus | 21 | 7 | 18 | 0 | <0.0001 | 50 | 13 | 19 | <0.0001 | Floor of the Mouth | 31 | 18 | 23 | 29 | 0 | 17 | 44 | Oral Tongue | 54 | 46 | 37 | 29 | 0 | 44 | 19 | Other | 35 | 29 | 23 | 43 | 50 | 26 | 19 | T Stage | | | | | | | | | | T1 | 42 | 36 | 29 | 14 | 0.001 | 50 | 30 | 26 | <0.00001 | T2 | 42 | 36 | 28 | 29 | 0 | 30 | 30 | T3/T4 | 57 | 29 | 42 | 57 | 50 | 39 | 44 | N Stage | | | | | | | | | | N0 | 74 | 43 | 56 | 43 | 0.137 | 50 | 54 | 48 | <0.00001 | N1/2a | 27 | 29 | 16 | 29 | 0 | 16 | 33 | N2b/2c/3 | 40 | 29 | 28 | 29 | 50 | 30 | 19 | Differentiation | | | | | | | | | | well | 17 | 7 | 13 | 14 | <0.001 | 0 | 13 | 7 | <0.0001 | moderate | 90 | 75 | 62 | 43 | 50 | 64 | 63 | poor | 34 | 18 | 25 | 43 | 50 | 22 | 30 | Perineural Invasion | | | | | | | | | Yes | 69 | 61 | 45 | 57 | 0.06 | 0 | 50 | 48 | <0.001 | No | 72 | 39 | 55 | 43 | 100 | 50 | 52 | Lymphovascular Invasion | | | | | | | | | Yes | 52 | 43 | 35 | 43 | 0.41 | 50 | 39 | 26 | 0.002 | No | 89 | 57 | 65 | 57 | 50 | 61 | 74 | Bone Invasion | | | | | | | | | | Yes | 42 | 21 | 68 | 29 | <0.001 | 50 | 29 | 30 | 0.002 | No | 99 | 79 | 32 | 71 | 50 | 71 | 70 | Radiotherapy | | | | | | | | | | Yes | 78 | 57 | 54 | 71 | 0.032 | 100 | 53 | 63 | <0.00001 | No | 63 | 43 | 46 | 29 | 0 | 47 | 37 | Chemotherapy | | | | | | | | | | Yes | 22 | 14 | 15 | 29 | 0.011 | 50 | 15 | 15 | <0.00001 | No | 119 | 86 | 85 | 71 | 50 | 85 | 85 |
|
|
Percentages may not sum to 100% due to rounding. |